JB Chemicals Q2 FY26: PAT up 16%, CCI clears Torrent acquisition
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals Q2 FY26 standalone revenue Rs 1,022.65 crore, up 7% YoY; net profit Rs 200.02 crore, up 15.6%. H1 revenue Rs 2,062.55 crore; PAT Rs 398.29 crore. Consolidated H1 revenue Rs 2,178.84 crore; PAT Rs 410.20 crore, up 16.7% YoY. CCI has approved Torrent Pharmaceuticals acquisition, progressing the merger; swap ratio fixed at 51 Torrent shares for every 100 JB Chemicals shares. Board approved the unaudited results with limited review by Deloitte Haskins and Sells.
Solid earnings growth and CCI nod for Torrent deal advance the merger; shareholders to get 51 Torrent shares per 100 held.